Medication info
Fosiglip M Tablet 10/100 Milligrams

Fosiglip M Tablet 10/100 Milligrams

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tabletDapagliflozin citric acid›14.7mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202200488 · Approved 2022.01.28 · Insurance code 622805060

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. No dose adjustment is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is below 45 mL/min/1.73 m2. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary and exercise regimens to assist in the blood sugar control of patients with type 2 diabetes who are using sitagliptin and dapagliflozin together. It helps effectively manage blood sugar and supports diabetes treatment.

Dosage and Administration

Adult dosage

This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. No dose adjustment is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is below 45 mL/min/1.73 m2. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Precautions

This medication contains sitagliptin and dapagliflozin and is used in the treatment of diabetes. Firstly, sitagliptin may cause serious allergic reactions in some patients, so if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur within the first 3 months after administration, treatment should be stopped immediately and a physician should be consulted. Additionally, acute pancreatitis, which is a serious side effect involving inflammation of the pancreas, has been reported, so if symptoms such as abdominal pain or vomiting occur, immediately discontinue the medication and notify healthcare personnel. Dapagliflozin should be used with caution in patients with impaired kidney function or reduced fluid volume. This medication may cause dehydration or hypotension due to its action of expelling glucose through urine, so elderly patients or those taking diuretics should regularly monitor blood pressure and kidney function. Furthermore, although rare, genital infections or urinary tract infections may occur, so immediate treatment should be sought if symptoms of infection appear. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or in patients with lactose intolerance; it is also advisable not to use it in patients undergoing dialysis. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, treatment should be stopped immediately. During treatment with this medication, symptoms of hypoglycemia may occur, so when used with other hypoglycemic agents such as insulin or sulfonylureas, dosage adjustment may be necessary to reduce the risk of hypoglycemia. In cases of overdose, since there is no specific antidote, appropriate treatment should be administered according to symptoms, and blood dialysis may be considered if necessary. Finally, this medication has not been established for safety and efficacy in children under 18 years of age, so it should not be used in this population. In elderly patients, it is important to periodically evaluate kidney function when administering this medication. Patients taking this medication should be aware of the potential risk of hypoglycemia when driving or operating machinery and exercise caution.

Side effects

  • Severe hypersensitivity
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • genital infection
  • vulvitis
  • balanitis
Show 173 more
  • urinary tract infection
  • fungal infection
  • perineal necrosis
  • hypoglycemia
  • dry mouth
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • elevated blood urea
  • weight loss
  • rash
  • acute pyelonephritis
  • asthenia
  • pain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute renal failure
  • upper respiratory infection
  • nasopharyngitis
  • vomiting
  • headache
  • severe arthralgia with disability
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • gastroesophageal reflux disease
  • epigastric pain
  • diverticulosis
  • intestinal perforation
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pulmonary tuberculosis
  • ligament sprain
  • road traffic accident
  • drug overdose
  • ankle fracture
  • hand fracture
  • iliac crest fracture
  • meniscus injury
  • thoracic spine fracture
  • tibial fracture
  • keratitis
  • angina
  • atrial fibrillation
  • diastolic dysfunction
  • palpitations
  • anxiety disorder
  • nocturia
  • insomnia
  • fatty liver
  • gallbladder polyp
  • dizziness
  • tinnitus
  • vaginal discharge
  • menstrual irregularities
  • pruritus
  • urticaria
  • diaphoresis
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • contusion
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • laceration
  • ligament rupture
  • skin abrasion
  • tendon rupture
  • dry eye
  • ocular pain
  • retinal disorder
  • decreased vision
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • glaucoma
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • voice disorder
  • epistaxis
  • sputum
  • sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • palpitations
  • anxiety disorder
  • nocturia
  • insomnia
  • bile duct stone
  • cholangitis
  • alcoholic cirrhosis
  • liver cyst
  • male reproductive gland deficiency
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • erythrocytosis
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • alanine aminotransferase elevation
  • aspartate aminotransferase elevation
  • weight gain
  • decreased appetite
  • edema
  • headache
  • nasopharyngitis
  • asthenia
  • hunger
  • vaginal discharge
  • pruritus
  • ligament sprain
  • diabetic retinopathy
  • cough
  • shortness of breath
  • orthostatic hypotension
  • palpitations
  • insomnia
  • tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to store it at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.